FOLD - Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Amicus Therapeutics
NEW YORK, NY / ACCESSWIRE / October 15, 2018 / U.S. markets bounced on Friday, erasing some of the losses for the week, as the third quarter earnings season kicked off. The Dow Jones Industrial Average jumped 1.15 percent to close at 25,339.99, while the S&P 500 Index increased 1.42 percent to close at 2,767.13. The Nasdaq Composite Index closed up 2.29 percent to close at 7,496.89.
According to Michael Arone, chief investment strategist for State Street Global Advisors, “Solid earnings helped investors breath a sign of relief.” Arone also said, “That gains accelerated towards the close indicates that investors are confident about the economy.”
RDI Initiates Coverage on:
Sarepta Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=SRPT
Amicus Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=FOLD
Sarepta Therapeutics' stock jumped 6.96% Friday, to close the day at $130.50. The stock recorded a trading volume of 1,376,452 shares, which was above its three months average volume of 1,092,106 shares. In the last year, Sarepta Therapeutics' shares have traded in a range of 46.07 - 176.50. The share price has gained 183.26% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $143.81 is above its 200-day moving average of $116.15. Shares of Sarepta Therapeutics have fallen roughly 14.57 percent in the past month and are up 134.54 percent year-to-date.
Access RDI's Sarepta Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SRPT
On Friday, shares of Amicus Therapeutics recorded a trading volume of 2,172,113 shares, which was above the three months average volume of 2,417,021 shares. The stock ended the day 5.45% higher at $12.39. The share price has fallen 29.68% from its 52 week high with a 52 week trading range of 11.57 - 17.62. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $12.53 is below its 200-day moving average of $14.42. Shares of Amicus Therapeutics have gained roughly 5.54 percent in the past month and are down 13.9 percent year-to-date.
Access RDI's Amicus Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=FOLD
Our Actionable Research on Sarepta Therapeutics, Inc. (NASDAQ :SRPT) and Amicus Therapeutics, Inc. (NASDAQ :FOLD) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com